rs564402674
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_001387283.1(SMARCA4):c.2617-110G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00348 in 1,371,434 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 14 hom. )
Consequence
SMARCA4
NM_001387283.1 intron
NM_001387283.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.111
Publications
1 publications found
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00193 (294/152316) while in subpopulation NFE AF = 0.00334 (227/68022). AF 95% confidence interval is 0.00298. There are 0 homozygotes in GnomAd4. There are 145 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 14 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.2617-110G>A | intron_variant | Intron 18 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.2617-110G>A | intron_variant | Intron 18 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000643549.1 | c.2617-110G>A | intron_variant | Intron 18 of 34 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000541122.6 | c.2617-110G>A | intron_variant | Intron 19 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.2617-110G>A | intron_variant | Intron 18 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.2617-110G>A | intron_variant | Intron 18 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.2617-110G>A | intron_variant | Intron 19 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.2029-110G>A | intron_variant | Intron 15 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.1261-110G>A | intron_variant | Intron 11 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.1342-110G>A | intron_variant | Intron 11 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.1102-110G>A | intron_variant | Intron 10 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.970-110G>A | intron_variant | Intron 9 of 24 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 294AN: 152198Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
294
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00209 AC: 296AN: 141710 AF XY: 0.00191 show subpopulations
GnomAD2 exomes
AF:
AC:
296
AN:
141710
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00367 AC: 4477AN: 1219118Hom.: 14 Cov.: 18 AF XY: 0.00358 AC XY: 2183AN XY: 609694 show subpopulations
GnomAD4 exome
AF:
AC:
4477
AN:
1219118
Hom.:
Cov.:
18
AF XY:
AC XY:
2183
AN XY:
609694
show subpopulations
African (AFR)
AF:
AC:
19
AN:
28258
American (AMR)
AF:
AC:
57
AN:
35490
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
24098
East Asian (EAS)
AF:
AC:
0
AN:
34916
South Asian (SAS)
AF:
AC:
63
AN:
75104
European-Finnish (FIN)
AF:
AC:
8
AN:
37268
Middle Eastern (MID)
AF:
AC:
2
AN:
5402
European-Non Finnish (NFE)
AF:
AC:
4183
AN:
926244
Other (OTH)
AF:
AC:
144
AN:
52338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
227
454
682
909
1136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00193 AC: 294AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.00195 AC XY: 145AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
294
AN:
152316
Hom.:
Cov.:
33
AF XY:
AC XY:
145
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
29
AN:
41578
American (AMR)
AF:
AC:
26
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
5
AN:
4824
European-Finnish (FIN)
AF:
AC:
4
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
227
AN:
68022
Other (OTH)
AF:
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link
Submissions by phenotype
not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.